The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...

This month's Patch Tuesday brings over 80 fixes for various security vulnerabilities. Fortunately, none are actively being ...

The U.S. Defense Department’s Golden Dome program is seeking a space-based interceptor with the thrust to intercept long-range ballistic and hypersonic missiles and the range to cover multiple ...

Company expands collaboration with DB HiTek towards AI in-memory-compute applications -- Weebit Nano Limited (ASX:WBT) ...

The company is competing with Microsoft and others to put AI into the hands of more office workers. Adding new Gemini functionality to Workspace takes a step towards that goal, say analysts, but ...

Analysts expect the market for manufacturing cell and gene therapies, worth less than $20 billion in 2024, to expand rapidly as approvals drive higher volumes of production.

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today confirmed that DOMA Perpetual ...

The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...

Deepfake and continuous identity protection programs must therefore be framed not as experimental controls, but as ROI-driven investments.

HM Exploration Corp. ("HM Exploration” or "HM” or the "Company”) (CSE:HM) is pleased to announce that it has entered into a property option agreement dated March 11, 2026 (the "Agreement”) to acquire ...

Four-legged robots that scramble up stairs, stride over rubble, and stream inspection data — no preorder, no lab coat required.